TipRanks
Quest Diagnostics (MX:DGX)
:DGX
Mexico Market

Quest Diagnostics (DGX) Ratios

0 Followers

Quest Diagnostics Ratios

MX:DGX's free cash flow for Q3 2026 was $0.34. For the 2026 fiscal year, MX:DGX's free cash flow was decreased by $ and operating cash flow was $0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.70 1.04 1.10 1.31 1.22
Quick Ratio
1.58 0.96 1.02 1.20 1.10
Cash Ratio
0.43 0.18 0.25 0.38 0.20
Solvency Ratio
0.19 0.17 0.15 0.17 0.20
Operating Cash Flow Ratio
1.06 0.83 0.62 0.70 1.11
Short-Term Operating Cash Flow Coverage
10.21 2.78 1.42 2.17 6.96
Net Current Asset Value
$ -6.07B$ -6.56B$ -6.87B$ -5.23B$ -4.93B
Leverage Ratios
Debt-to-Assets Ratio
0.36 0.43 0.44 0.39 0.37
Debt-to-Equity Ratio
0.82 0.96 1.05 0.87 0.80
Debt-to-Capital Ratio
0.45 0.49 0.51 0.47 0.44
Long-Term Debt-to-Capital Ratio
0.44 0.44 0.45 0.41 0.40
Financial Leverage Ratio
2.26 2.26 2.38 2.22 2.18
Debt Service Coverage Ratio
4.41 1.97 1.39 1.98 3.94
Interest Coverage Ratio
6.80 5.79 5.96 7.74 9.65
Debt to Market Cap
0.23 0.33 0.39 0.32 0.23
Interest Debt Per Share
59.45 64.83 65.88 50.54 41.91
Net Debt to EBITDA
2.38 2.96 3.45 2.78 2.42
Profitability Margins
Gross Profit Margin
33.15%31.93%32.86%33.17%34.74%
EBIT Margin
14.51%14.72%14.19%13.98%13.99%
EBITDA Margin
19.45%19.88%19.19%18.72%18.42%
Operating Profit Margin
14.59%14.53%13.63%13.64%14.45%
Pretax Profit Margin
12.66%12.32%12.09%12.49%12.94%
Net Profit Margin
9.53%8.99%8.82%9.23%9.57%
Continuous Operations Profit Margin
9.77%9.48%9.33%9.81%10.27%
Net Income Per EBT
75.32%72.94%72.95%73.88%73.96%
EBT Per EBIT
86.75%84.84%88.71%91.60%89.57%
Return on Assets (ROA)
6.56%6.11%5.39%6.09%7.37%
Return on Equity (ROE)
15.21%13.84%12.85%13.54%16.05%
Return on Capital Employed (ROCE)
11.23%11.49%9.63%10.34%12.65%
Return on Invested Capital (ROIC)
8.56%8.43%6.96%7.75%9.83%
Return on Tangible Assets
17.44%17.58%15.74%16.67%20.91%
Earnings Yield
4.08%5.15%5.20%5.53%5.21%
Efficiency Ratios
Receivables Turnover
6.92 7.84 7.57 7.65 8.27
Payables Turnover
4.82 4.70 23.09 16.40 19.91
Inventory Turnover
36.31 39.75 35.26 32.63 33.59
Fixed Asset Turnover
4.02 3.86 3.57 3.83 4.20
Asset Turnover
0.69 0.68 0.61 0.66 0.77
Working Capital Turnover Ratio
10.12 68.33 25.31 20.47 14.81
Cash Conversion Cycle
-12.93 -21.99 42.76 36.67 36.66
Days of Sales Outstanding
52.77 46.57 48.21 47.74 44.13
Days of Inventory Outstanding
10.05 9.18 10.35 11.19 10.87
Days of Payables Outstanding
75.76 77.74 15.80 22.26 18.33
Operating Cycle
62.82 55.76 58.57 58.92 55.00
Cash Flow Ratios
Operating Cash Flow Per Share
17.74 16.99 12.02 11.36 14.81
Free Cash Flow Per Share
12.50 12.24 8.19 7.71 11.33
CapEx Per Share
5.24 4.75 3.83 3.64 3.48
Free Cash Flow to Operating Cash Flow
0.70 0.72 0.68 0.68 0.76
Dividend Paid and CapEx Coverage Ratio
2.06 2.14 1.76 1.76 2.42
Capital Expenditure Coverage Ratio
3.39 3.58 3.14 3.12 4.25
Operating Cash Flow Coverage Ratio
0.31 0.27 0.19 0.23 0.36
Operating Cash Flow to Sales Ratio
0.16 0.17 0.14 0.14 0.17
Free Cash Flow Yield
4.95%7.06%5.43%5.59%7.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
24.74 19.56 19.23 18.08 19.18
Price-to-Sales (P/S) Ratio
2.35 1.75 1.70 1.67 1.84
Price-to-Book (P/B) Ratio
3.63 2.69 2.47 2.45 3.08
Price-to-Free Cash Flow (P/FCF) Ratio
20.21 14.17 18.42 17.87 13.81
Price-to-Operating Cash Flow Ratio
14.20 10.21 12.55 12.14 10.56
Price-to-Earnings Growth (PEG) Ratio
1.39 1.43 6.95 -2.77 -0.39
Enterprise Value Multiple
14.45 11.74 12.29 11.69 12.39
Enterprise Value
33.28B 25.76B 23.28B 20.25B 22.55B
EV to EBITDA
14.45 11.74 12.29 11.69 12.39
EV to Sales
2.81 2.33 2.36 2.19 2.28
EV to Free Cash Flow
24.21 18.96 25.61 23.44 17.16
EV to Operating Cash Flow
17.06 13.66 17.45 15.92 13.12
Tangible Book Value Per Share
-24.68 -29.68 -33.54 -22.15 -19.87
Shareholders’ Equity Per Share
69.38 64.59 61.06 56.31 50.80
Tax and Other Ratios
Effective Tax Rate
0.23 0.23 0.23 0.21 0.21
Revenue Per Share
107.65 99.41 88.94 82.61 85.20
Net Income Per Share
10.26 8.94 7.85 7.63 8.16
Tax Burden
0.75 0.73 0.73 0.74 0.74
Interest Burden
0.87 0.84 0.85 0.89 0.92
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.17 0.18 0.18 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.67 1.80 1.45 1.40 1.69
Currency in USD